205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
4.70%
Revenue growth below 50% of MCHP's 10.82%. Michael Burry would check for competitive disadvantage risks.
-33.41%
Cost reduction while MCHP shows 6.26% growth. Joel Greenblatt would examine competitive advantage.
171.79%
Gross profit growth exceeding 1.5x MCHP's 15.09%. David Dodd would verify competitive advantages.
159.59%
Margin expansion exceeding 1.5x MCHP's 3.85%. David Dodd would verify competitive advantages.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
181.90%
Operating expenses growth while MCHP reduces costs. John Neff would investigate differences.
6.89%
Total costs growth while MCHP reduces costs. John Neff would investigate differences.
No Data
No Data available this quarter, please select a different quarter.
450.00%
D&A growth while MCHP reduces D&A. John Neff would investigate differences.
-560.00%
EBITDA decline while MCHP shows 144.00% growth. Joel Greenblatt would examine position.
-530.36%
EBITDA margin decline while MCHP shows 120.17% growth. Joel Greenblatt would examine position.
-1233.33%
Operating income decline while MCHP shows 132.00% growth. Joel Greenblatt would examine position.
-1173.45%
Operating margin decline while MCHP shows 128.88% growth. Joel Greenblatt would examine position.
-366.67%
Other expenses reduction while MCHP shows 29.56% growth. Joel Greenblatt would examine advantage.
-800.00%
Pre-tax income decline while MCHP shows 90.61% growth. Joel Greenblatt would examine position.
-759.58%
Pre-tax margin decline while MCHP shows 91.53% growth. Joel Greenblatt would examine position.
100.00%
Similar tax expense growth to MCHP's 120.44%. Walter Schloss would investigate patterns.
-700.00%
Net income decline while MCHP shows 87.97% growth. Joel Greenblatt would examine position.
-664.07%
Net margin decline while MCHP shows 89.14% growth. Joel Greenblatt would examine position.
-445.24%
EPS decline while MCHP shows 70.34% growth. Joel Greenblatt would examine position.
-445.24%
Diluted EPS decline while MCHP shows 70.34% growth. Joel Greenblatt would examine position.
0.04%
Share count reduction exceeding 1.5x MCHP's 0.33%. David Dodd would verify capital allocation.
0.04%
Diluted share reduction exceeding 1.5x MCHP's 0.33%. David Dodd would verify capital allocation.